Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Torun – page 73

918 clinical trials in Torun, Poland across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Torun at a glance
918
clinical trials
  • Research sites2
Type of trial
Recruitment status
Quick filters

918 trials in Torun

Open in trial search

Renal cell carcinoma

Not recruiting

Study of Pembrolizumab, Favezelimab, and Lenvatinib for Patients with Renal Cell Carcinoma

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Belzutifan
  • Sponsor:Merck Sharp & Dohme LLC

HIV infection

Not recruiting

Study Comparing Dolutegravir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide for HIV Treatment in Adults New to Antiretroviral Therapy

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Bictegravir
  • Sponsor:Viiv Healthcare UK Limited

Study of BGB-A425, LBL-007, and Tislelizumab for Patients with Advanced Head and Neck Cancer, Lung Cancer, or Kidney Cancer

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:LBL-007
  • Sponsor:Beigene Ltd.

Study on Ertugliflozin for Children and Teens with Type 2 Diabetes

Investigational
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Ertugliflozin
  • Sponsor:Merck Sharp & Dohme LLC

Axial spondyloarthritis+1

Not recruiting

Study on Upadacitinib for Adults with Active Axial Spondyloarthritis

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Upadacitinib
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Renal cell carcinoma

Not recruiting

Study on the Safety and Effectiveness of Pembrolizumab for Patients with Kidney Cancer After Surgery

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Merck Sharp & Dohme LLC

Study of Pembrolizumab and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Enzalutamide
  • Sponsor:Merck Sharp & Dohme LLC

Study on the Safety and Effectiveness of Stereotactic Body Radiotherapy with or without Pembrolizumab for Patients with Unresected Stage I or II Non-Small Cell Lung Cancer

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Merck Sharp & Dohme LLC

Study of Pembrolizumab and Chemotherapy for Patients with Triple Negative Breast Cancer

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Merck Sharp & Dohme LLC

Psoriasis

Not recruiting

Study on the Effectiveness and Safety of HRO350 for Patients with Mild-to-Moderate Psoriasis

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Pehero
  • Sponsor:Arctic Bioscience AS

Colitis ulcerative+2

Not recruiting

Study on Long-term Safety of Ustekinumab for Children with Crohn's Disease, Juvenile Psoriatic Arthritis, or Ulcerative Colitis

Registered drugNo placebo
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Ustekinumab
  • Sponsor:Janssen Cilag International

Study on the V116 Vaccine for Adults Aged 18-64 at Increased Risk of Pneumococcal Infection

Registered drug
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:ABC-15BO-116
  • Sponsor:Merck Sharp & Dohme LLC

Other cities in Poland

The busiest research cities in the country

All 236 cities in Poland

Clinical research in Torun

What the registry says about research in the country

01 Infectious Disease Prevention

Clinical research focusing on vaccine development for various infectious diseases, including studies on chickenpox, meningococcal, and pneumococcal vaccines. Trials evaluate immune responses in children and toddlers.

  • Varicella vaccine studies
  • Meningococcal ACYW research
  • Pneumococcal conjugate vaccines

These studies aim to enhance protection against common childhood infections through innovative immunization strategies.

02 Autoimmune Conditions

Extensive research into treatments for inflammatory disorders, with particular focus on novel therapies for conditions affecting joints and skin.

  • Psoriatic Arthritis treatments
  • Ulcerative Colitis therapies
  • Atopic Dermatitis solutions

Clinical trials are evaluating new biological and small molecule treatments to improve patient outcomes.

03 Oncology and Hematology

Advanced research in blood cancers and related conditions, focusing on innovative therapeutic approaches.

  • Acute Myeloid Leukemia treatments
  • Chronic Lymphocytic Leukemia therapies
  • Prostate Cancer interventions

Studies evaluate combination therapies and novel compounds for improved treatment outcomes.

04 Chronic Disease Management

Research targeting long-term conditions affecting quality of life, including cardiovascular and joint disorders.

  • Heart Failure prevention
  • Osteoarthritis treatments
  • IgA Nephropathy studies

Trials focus on developing therapeutic solutions for chronic condition management.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.